About Enhancer

Enhancer ID: E_02_0489
Species: human
Position : chr14:100235593-100237593
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: --
Pubmed ID:  30098214
Enhancer experiment: RT ? PCR, Weston blot, flow cytometry, statistical analysis, chromatin immunoprecipitation assays, gene knockdown
Enhancer experiment description: Ei and E3 are both required for Ig? gene rearrangement during early stages of B cell development, whereas optimal expression of the rearranged Ig? gene relies on both E3 and Ed. The transcription factor YY1 affects the expression of many genes involved in B cell development, probably by mediating interactions between their enhancers and promoters.Herein, we found that YY1 binds to the E3 enhancer and suppresses Ig? expression in B lymphoma cells by epigenetically modifying the enhancer. Knocking down YY1 enhanced Ig? expression, which was associated with increased levels of E2A (encoded by the TCF3 gene) and its binding to the E3 enhancer.

About Target gene

Target gene : YY1(DELTA,GADEVS,INO80S,NF-E1,UCRBP,YIN-YANG-1),TCF3
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: Ei and E3 are both required for Ig? gene rearrangement during early stages of B cell development, whereas optimal expression of the rearranged Ig? gene relies on both E3 and Ed. The transcription factor YY1 affects the expression of many genes involved in B cell development, probably by mediating interactions between their enhancers and promoters.Herein, we found that YY1 binds to the E3 enhancer and suppresses Ig? expression in B lymphoma cells by epigenetically modifying the enhancer. Knocking down YY1 enhanced Ig? expression, which was associated with increased levels of E2A (encoded by the TCF3 gene) and its binding to the E3 enhancer. ;Ei and E3 are both required for Ig? gene rearrangement during early stages of B cell development, whereas optimal expression of the rearranged Ig? gene relies on both E3 and Ed. The transcription factor YY1 affects the expression of many genes involved in B cell development, probably by mediating interactions between their enhancers and promoters.Herein, we found that YY1 binds to the E3 enhancer and suppresses Ig? expression in B lymphoma cells by epigenetically modifying the enhancer. Knocking down YY1 enhanced Ig? expression, which was associated with increased levels of E2A (encoded by the TCF3 gene) and its binding to the E3 enhancer.

About TF

TF name : --
TF experiment: RT?PCR,weston blot,?????,????,Chromatin immunoprecipitation assays,????
TF experiment description: Ei and E3 are both required for Ig? gene rearrangement during early stages of B cell development, whereas optimal expression of the rearranged Ig? gene relies on both E3 and Ed. The transcription factor YY1 affects the expression of many genes involved in B cell development, probably by mediating interactions between their enhancers and promoters.Herein, we found that YY1 binds to the E3 enhancer and suppresses Ig? expression in B lymphoma cells by epigenetically modifying the enhancer. Knocking down YY1 enhanced Ig? expression, which was associated with increased levels of E2A (encoded by the TCF3 gene) and its binding to the E3 enhancer. ;Ei and E3 are both required for Ig? gene rearrangement during early stages of B cell development, whereas optimal expression of the rearranged Ig? gene relies on both E3 and Ed. The transcription factor YY1 affects the expression of many genes involved in B cell development, probably by mediating interactions between their enhancers and promoters.Herein, we found that YY1 binds to the E3 enhancer and suppresses Ig? expression in B lymphoma cells by epigenetically modifying the enhancer. Knocking down YY1 enhanced Ig? expression, which was associated with increased levels of E2A (encoded by the TCF3 gene) and its binding to the E3 enhancer.

About Function

Enhancer function : Ei and E3 are both required for Ig? gene rearrangement during early stages of B cell development, whereas optimal expression of the rearranged Ig? gene relies on both E3 and Ed. The transcription factor YY1 affects the expression of many genes involved in B cell development, probably by mediating interactions between their enhancers and promoters.Herein, we found that YY1 binds to the E3 enhancer and suppresses Ig? expression in B lymphoma cells by epigenetically modifying the enhancer. Knocking down YY1 enhanced Ig? expression, which was associated with increased levels of E2A (encoded by the TCF3 gene) and its binding to the E3 enhancer.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
Ei and E3 are both required for Ig? gene rearrangement during early stages of B cell development, whereas optimal expression of the rearranged Ig? gene relies on both E3 and Ed. The transcription factor YY1 affects the expression of many genes involved in B cell development, probably by mediating interactions between their enhancers and promoters.Herein, we found that YY1 binds to the E3 enhancer and suppresses Ig? expression in B lymphoma cells by epigenetically modifying the enhancer. Knocking down YY1 enhanced Ig? expression, which was associated with increased levels of E2A (encoded by the TCF3 gene) and its binding to the E3 enhancer.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs